Journal Article |
| Barber AG, Quintero CM, Hamilton M, Rajbhandari N, Sasik R, Zhang Y, Kim C, Husain H, Sun X, Reya T, Regulation of lung cancer initiation and progression by the stem cell determinant Musashi. eLife, 2025 Mar 6;13 | 2025 |
| Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, Gulay KCM, Sharma S, Sood D, Wenzel AT, Martsinkovskiy A, Rajbhandari N, Patel J, Jaquish D, Esparza E, Jaque K, Aggarwal N, Lambies G, D'Ippolito A, Austgen K, Johnston B, Orlando DA, Jang GH, Gallinger S, Goodfellow E, Brodt P, Commisso C, Tamayo P, Mesirov JP, Tiriac H, Lowy AM, MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Cancer research, 2025 Mar 14;85(6):1049-1063 | 2025 |
| Rajbhandari N, Diaz E, Kritzik M, Reya T, Imaging Approaches in Cancer Biology. Cold Spring Harbor perspectives in medicine, 2024 Sep 3;14(9) | 2024 |
| Shrestha H, Rädler PD, Dennaoui R, Wicker MN, Rajbhandari N, Sun Y, Peck AR, Vistisen K, Triplett AA, Beydoun R, Sterneck E, Saur D, Rui H, Wagner KU, The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Cell reports, 2024 May 28;43(5):114202 | 2024 |
| Rajbhandari N, Hamilton M, Quintero CM, Ferguson LP, Fox R, Schürch CM, Wang J, Nakamura M, Lytle NK, McDermott M, Diaz E, Pettit H, Kritzik M, Han H, Cridebring D, Wen KW, Tsai S, Goggins MG, Lowy AM, Wechsler-Reya RJ, Von Hoff DD, Newman AM, Reya T, Single-cell mapping identifies MSI(+) cells as a common origin for diverse subtypes of pancreatic cancer. Cancer cell, 2023 Nov 13;41(11):1989-2005.e9 | 2023 |
| Ferguson LP, Gatchalian J, McDermott ML, Nakamura M, Chambers K, Rajbhandari N, Lytle NK, Rosenthal SB, Hamilton M, Albini S, Wartenberg M, Zlobec I, Galván JA, Karamitopoulou E, Vavinskaya V, Wascher A, Lowy AM, Schürch CM, Puri PL, Bruneau BG, Hargreaves DC, Reya T, Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Nature communications, 2023 Jan 18;14(1):292 | 2023 |
| Lenkiewicz E, Malasi S, Hogenson TL, Flores LF, Barham W, Phillips WJ, Roesler AS, Chambers KR, Rajbhandari N, Hayashi A, Antal CE, Downes M, Grandgenett PM, Hollingsworth MA, Cridebring D, Xiong Y, Lee JH, Ye Z, Yan H, Hernandez MC, Leiting JL, Evans RM, Ordog T, Truty MJ, Borad MJ, Reya T, Von Hoff DD, Fernandez-Zapico ME, Barrett MT, Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas. Cancer research, 2020 Oct 15;80(20):4324-4334 | 2020 |
| Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T, A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell, 2019 Apr 18;177(3):572-586.e22 | 2019 |
| Rajbhandari N, Lin WC, Wehde BL, Triplett AA, Wagner KU, Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers. Cell reports, 2017 Feb 28;18(9):2243-2255 | 2017 |
| Sakamoto K, Wehde BL, Yoo KH, Kim T, Rajbhandari N, Shin HY, Triplett AA, Rädler PD, Schuler F, Villunger A, Kang K, Hennighausen L, Wagner KU, Janus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling. Molecular and cellular biology, 2016 Jun 1;36(11):1673-90 | 2016 |
| Lin WC, Rajbhandari N, Wagner KU, Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies. Cancer research, 2014 Apr 15;74(8):2138-43 | 2014 |
| Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP 4th, Hebrok M, Witkiewicz AK, Brody JR, Rui H, Wagner KU, Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer research, 2013 Mar 15;73(6):1821-30 | 2013 |
